David L. Rimm

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Quantification of Antibody–Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma

  Molecular Cancer Therapeutics · 2026-04-20

• Temperature-Dependent Long-term and Short-term Stability of Human Epidermal Growth Factor 2 Antigenicity on Pathology Slides

  Archives of Pathology & Laboratory Medicine · 2026-04-17

• Pathological response to herceptin-containing neoadjuvant therapy in HER2 IHC2+/ISH+ and IHC3+ early-stage invasive ductal carcinoma

  Human Pathology · 2026-04-14

• Abstract 1220: Spatial transcriptomics revealed potential resistance and response factors of sacituzumab govitecan in metastatic breast cancer.

  Cancer Research · 2026-04-03

• Abstract 80: Quantitative assessment of tumor-infiltrating lymphocytes using AI in non-small cell lung cancer and association with immunotherapy response.

  Cancer Research · 2026-04-03

• Abstract 4121: Incorporation of cut-point robustness in the discovery and evaluation of molecular cancer biomarkers using SCRIBE (Survival Cut-point Reporting and Integrative Biomarker Evaluation)

  Cancer Research · 2026-04-03

• Abstract 7742: Intratumoral effector T-cells and macrophages underlie prolonged survival after PD-1 axis blockade in metastatic non-small cell lung cancer (mNSCLC)

  Cancer Research · 2026-04-03

• Abstract 1222: Spatial transcriptomics of trastuzumab deruxtecan-treated metastatic breast cancer identifies candidate response and resistance factors.

  Cancer Research · 2026-04-03

• Quantitative HER2 tissue and plasma profiling predicts the activity of trastuzumab deruxtecan for breast cancer

  npj Precision Oncology · 2026-03-13 · 1 citations

• A Single-Cell Spatially-Resolved Human Whole Transcriptome Atlas of Non-Small Cell Lung Cancer (NSCLC)

  Open MIND · 2026-03-05

• A Single-Cell Spatially-Resolved Human Whole Transcriptome Atlas of Non-Small Cell Lung Cancer (NSCLC)

  Zenodo (CERN European Organization for Nuclear Research) · 2026-03-05

• Quantitative Assays for TROP2 Measurement in Breast Cancer and Comparison to H-Score

  Applied immunohistochemistry & molecular morphology · 2026-02-19 · 1 citations

• Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)

  Nature Communications · 2026-02-03 · 2 citations

• STING predicts patterns of failure in locally advanced head and neck squamous cell carcinoma

  JNCI Cancer Spectrum · 2026-01-17

• Pathological Response to Herceptin-containing Neoadjuvant Therapy in HER2 IHC2+/ISH+ and IHC3+ Early-Stage Invasive Ductal CarcinomaPreprint

  SSRN Electronic Journal · 2026-01-01

• Automated scoring of tumour infiltrating lymphocytes informs risk of death from thin melanoma: a nested case-case study [Supplementary Tables]

  Mendeley Data · 2025-12-25

• Figure S2 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

  2025-11-25

• Figure S7 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

  2025-11-25

• Figure S8 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

  2025-11-25

• Figure S4 from Subsets of IFN Signaling Predict Response to Immune Checkpoint Blockade in Patients with Melanoma

  2025-11-25